dalteparin has been researched along with Left Ventricular Outflow Obstruction in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Blanche, LE | 1 |
| Schmitz, ML | 1 |
| Johnson, CE | 1 |
| Best, TH | 1 |
| Drummond-Webb, JJ | 1 |
1 review available for dalteparin and Left Ventricular Outflow Obstruction
| Article | Year |
|---|---|
Successful surgical management of a neonate with a saddle pulmonary embolus.
Topics: Anticoagulants; Arm; Cardiopulmonary Bypass; Ductus Arteriosus, Patent; Embolectomy; Enoxaparin; Fem | 2004 |